Stonegate Investment Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,002
Closed -$207K 413
2024
Q2
$207K Buy
1,002
+26
+3% +$5.89K 0.01% 335
2024
Q1
$264K Buy
+976
New +$233K 0.01% 272
2023
Q4
Sell
-1,025
Closed -$201K 348
2023
Q3
$201K Sell
1,025
-141
-12% -$28.9K 0.01% 279
2023
Q2
$245K Buy
1,166
+61
+6% +$12.1K 0.01% 276
2023
Q1
$223K Buy
1,105
+85
+8% +$19.3K 0.01% 286
2022
Q4
$222K Sell
1,020
-88
-8% -$19.2K 0.01% 280
2022
Q3
$218K Buy
1,108
+112
+11% +$24.2K 0.01% 253
2022
Q2
$213K Buy
996
+87
+10% +$21.3K 0.01% 264
2022
Q1
$258K Buy
909
+244
+37% +$75.2K 0.01% 219
2021
Q4
$251K Buy
+665
New +$258K 0.01% 228

Other funds holding CRL